These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 39071677)

  • 1. Suppress the cell growth of cancer stem-like cells (NTERA-2) using Sox2-Oct4 decoy oligodeoxynucleotide-encapsulated niosomes-zinc hybrid nanocarriers under X-irradiation.
    Johari B; Tavangar-Roosta S; Gharbavi M; Sharafi A; Kaboli S; Rezaeejam H
    Heliyon; 2024 Jul; 10(13):e34096. PubMed ID: 39071677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combinational therapy with Myc decoy oligodeoxynucleotides encapsulated in nanocarrier and X-irradiation on breast cancer cells.
    Johari B; Parvinzad Leilan M; Gharbavi M; Mortazavi Y; Sharafi A; Rezaeejam H
    Oncol Res; 2023; 32(2):309-323. PubMed ID: 38186581
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Targeting c-Myc with decoy oligodeoxynucleotide-loaded polycationic nanoparticles inhibits cell growth and induces apoptosis in cancer stem-like cells (NTERA-2).
    Ghorbani R; Gharbavi M; Keshavarz B; Madanchi H; Johari B
    Mol Biol Rep; 2024 May; 51(1):623. PubMed ID: 38710891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. NANOG Decoy Oligodeoxynucleotide-Encapsulated Niosomes Nanocarriers: A Promising Approach to Suppress the Metastatic Properties of U87 Human Glioblastoma Multiforme Cells.
    Gharbavi M; Johari B; Rismani E; Mousazadeh N; Taromchi AH; Sharafi A
    ACS Chem Neurosci; 2020 Dec; 11(24):4499-4515. PubMed ID: 33283497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increasing the colon cancer cells sensitivity toward radiation therapy via application of Oct4-Sox2 complex decoy oligodeoxynucleotides.
    Johari B; Rezaeejam H; Moradi M; Taghipour Z; Saltanatpour Z; Mortazavi Y; Nasehi L
    Mol Biol Rep; 2020 Sep; 47(9):6793-6805. PubMed ID: 32865703
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Simultaneous targeted inhibition of Sox2-Oct4 transcription factors using decoy oligodeoxynucleotides to repress stemness properties in mouse embryonic stem cells.
    Johari B; Zargan J
    Cell Biol Int; 2017 Dec; 41(12):1335-1344. PubMed ID: 28833847
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Targeted anti-tumor synergistic effects of Myc decoy oligodeoxynucleotides-loaded selenium nanostructure combined with chemoradiotherapy on LNCaP prostate cancer cells.
    Ghorbani R; Gharbavi M; Sharafi A; Rismani E; Rezaeejam H; Mortazavi Y; Johari B
    Oncol Res; 2023; 32(1):101-125. PubMed ID: 38188680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Oct4-Sox2 complex decoy oligodeoxynucleotides strategy on reverse epithelial to mesenchymal transition (EMT) induction in HT29-ShE encompassing enriched cancer stem-like cells.
    Bigdelou Z; Mortazavi Y; Saltanatpour Z; Asadi Z; Kadivar M; Johari B
    Mol Biol Rep; 2020 Mar; 47(3):1859-1869. PubMed ID: 32016633
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Investigation of specific binding of designed oligodeoxynucleotide decoys to transcription factors in HT29 cell line undergoing epithelial-mesenchymal transition (EMT).
    Bigdelou Z; Johari B; Kadivar M; Rismani E; Asadi Z; Rahmati M; Saltanatpour Z
    J Cell Physiol; 2019 Dec; 234(12):22765-22774. PubMed ID: 31115051
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of STAT3 decoy oligodeoxynucleotides' synergistic effects on radiation and/or chemotherapy in metastatic breast cancer cell line.
    Johari B; Rahmati M; Nasehi L; Mortazavi Y; Faghfoori MH; Rezaeejam H
    Cell Biol Int; 2020 Dec; 44(12):2499-2511. PubMed ID: 32841450
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hybrid of niosomes and bio-synthesized selenium nanoparticles as a novel approach in drug delivery for cancer treatment.
    Gharbavi M; Johari B; Mousazadeh N; Rahimi B; Leilan MP; Eslami SS; Sharafi A
    Mol Biol Rep; 2020 Sep; 47(9):6517-6529. PubMed ID: 32767222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application of Transcription Factor Decoy Oligodeoxynucleotides (ODNs) for Cancer Therapy.
    Johari B; Moradi M
    Methods Mol Biol; 2022; 2521():207-230. PubMed ID: 35733000
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myc Decoy Oligodeoxynucleotide Inhibits Growth and Modulates Differentiation of Mouse Embryonic Stem Cells as a Model of Cancer Stem Cells.
    Johari B; Ebrahimi-Rad M; Maghsood F; Lotfinia M; Saltanatpouri Z; Teimoori-Toolabi L; Sharifzadeh Z; Karimipoor M; Kadivar M
    Anticancer Agents Med Chem; 2017; 17(13):1786-1795. PubMed ID: 28403778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of decoy oligodeoxynucleotides strategy for inhibition of cell growth and reduction of metastatic properties in nonresistant and erlotinib-resistant SW480 cell line.
    Asadi Z; Fathi M; Rismani E; Bigdelou Z; Johari B
    Cell Biol Int; 2021 May; 45(5):1001-1014. PubMed ID: 33377576
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppressing the metastatic properties of the breast cancer cells using STAT3 decoy oligodeoxynucleotides: A promising approach for eradication of cancer cells by differentiation therapy.
    Rahmati M; Johari B; Kadivar M; Rismani E; Mortazavi Y
    J Cell Physiol; 2020 Jun; 235(6):5429-5444. PubMed ID: 31912904
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zinc nanoparticles coated with doxorubicin-conjugated alginate as a radiation sensitizer in triple-negative breast cancer cells.
    Asadi N; Gharbavi M; Rezaeejam H; Farajollahi A; Johari B
    Int J Pharm; 2024 Jun; 659():124285. PubMed ID: 38821433
    [TBL] [Abstract][Full Text] [Related]  

  • 17. HIF-1α decoy oligodeoxynucleotides inhibit HIF-1α signaling and breast cancer proliferation.
    Zhu X; Li Q; Li S; Chen B; Zou H
    Int J Oncol; 2015 Jan; 46(1):215-22. PubMed ID: 25334080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. OCT4&SOX2-specific cytotoxic T lymphocytes plus programmed cell death protein 1 inhibitor presented with synergistic effect on killing lung cancer stem-like cells in vitro and treating drug-resistant lung cancer mice in vivo.
    Zhang X; Hu F; Li C; Zheng X; Zhang B; Wang H; Tao G; Xu J; Zhang Y; Han B
    J Cell Physiol; 2019 May; 234(5):6758-6768. PubMed ID: 30382588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of overexpression of Oct4 and Sox2 genes on the biological and oncological characteristics of gastric cancer cells.
    Chen B; Zhu Z; Li L; Ye W; Zeng J; Gao J; Wang S; Zhang L; Huang Z
    Onco Targets Ther; 2019; 12():4667-4682. PubMed ID: 31417271
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibitory effects of STAT3 decoy oligodeoxynucleotides on human epithelial ovarian cancer cell growth in vivo.
    Zhang X; Liu P; Zhang B; Mao H; Shen L; Ma Y
    Int J Mol Med; 2013 Sep; 32(3):623-8. PubMed ID: 23828376
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.